欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1821/001
药品名称Nasonex
活性成分
    • Mometasone 50.0 µg
剂型Nasal spray, suspension
上市许可持有人N.V. Organon
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      NASONEX
    • Denmark (DK)
      Nasonex
    • Belgium (BE)
    • Luxembourg (LU)
      Nasonex
    • Ireland (IE)
    • Austria (AT)
      Nasonex aquosum - Nasenspray
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
      NASONEX
    • Greece (GR)
    • Finland (FI)
      Nasonex
    • Netherlands (NL)
    • Iceland (IS)
    • France (FR)
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2008/04/05
最近更新日期2024/11/29
药物ATC编码
    • R01 NASAL PREPARATIONS
    • R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
    • R01AD Corticosteroids
    • R RESPIRATORY SYSTEM
    • R01AD09 mometasone
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase